BARINGS LLC - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 203 filers reported holding PDL BIOPHARMA INC in Q2 2015. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.

Quarter-by-quarter ownership
BARINGS LLC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q1 2018$189,000
+7.4%
64,4000.0%0.00%
+50.0%
Q4 2017$176,000
-19.3%
64,4000.0%0.00%
-50.0%
Q3 2017$218,000
+37.1%
64,4000.0%0.00%
-20.0%
Q2 2017$159,000
-45.5%
64,400
-50.0%
0.01%
+66.7%
Q1 2017$292,000
+113.1%
128,800
+100.0%
0.00%0.0%
Q4 2016$137,000
-36.6%
64,4000.0%0.00%
-50.0%
Q3 2016$216,000
+6.9%
64,4000.0%0.01%
+20.0%
Q2 2016$202,000
-66.2%
64,400
-64.1%
0.01%
-37.5%
Q1 2016$598,000
+168.2%
179,600
+184.6%
0.01%
+33.3%
Q4 2015$223,000
-29.7%
63,1000.0%0.01%
-25.0%
Q3 2015$317,000
+359.4%
63,100
+489.7%
0.01%
+300.0%
Q2 2015$69,000
-8.0%
10,7000.0%0.00%0.0%
Q1 2015$75,000
-20.2%
10,700
-12.3%
0.00%0.0%
Q4 2014$94,000
+3.3%
12,2000.0%0.00%0.0%
Q3 2014$91,000
-42.8%
12,200
-25.6%
0.00%
-60.0%
Q2 2014$159,000
+2.6%
16,400
-11.8%
0.01%0.0%
Q1 2014$155,000
-1.3%
18,6000.0%0.01%
-28.6%
Q4 2013$157,000
-9.2%
18,600
-14.3%
0.01%0.0%
Q3 2013$173,00021,7000.01%
Other shareholders
PDL BIOPHARMA INC shareholders Q2 2015
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 2,632,000$8,817,0002.83%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 551,804$1,848,543,0001.54%
Nine Chapters Capital Management LLC 24,300$81,0000.57%
GREAT POINT PARTNERS LLC 645,000$2,161,0000.55%
Virtus ETF Advisers LLC 198,901$666,0000.32%
GSA CAPITAL PARTNERS LLP 1,521,224$5,096,0000.27%
Amici Capital, LLC 200,000$670,0000.18%
Acrospire Investment Management LLC 70,622$237,0000.16%
RBF Capital, LLC 273,976$918,0000.16%
SECOR Capital Advisors, LP 383,971$1,286,0000.14%
View complete list of PDL BIOPHARMA INC shareholders